Skip to main content
. 2014 Dec 10;9(12):e114128. doi: 10.1371/journal.pone.0114128

Table 1. Clinical characteristics of the Ansung and Ansan cohorts and the exclusion criteria for each biochemical trait.

Ansung Ansan p-value Exclusion criteria
Categorical Variables Chi-square test p-value
n (number of individuals) 4205 4637
Sex ratio (Male/Female) 0.76 (1809/2396) 1.05 (2374/2263) <0.001
Continuous Variables (mean +– standard deviation) t-test p-value
Age (years) 55.67±8.74 49.08±7.86 <0.001
Body weight (kg) 61.33±9.91 64.67±10.04 <0.001
Body mass index (BMI, kg/m2) 24.46±3.29 24.72±2.96 <0.001
Fasting glucose (GLU0, mg/dl) 83.42±9.70 84.25±9.89 <0.001 >126 mg/dl, and T2DM history
Albumin (ALB, g/dl) 4.16±0.25 4.33±0.33 <0.001 <3.8, >5.1 g/dl
Blood urea nitrogen (BUN, mg/dl) 13.70±3.00 13.73±2.87 0.592 <6, >20 mg/dl
Gamma glutamyl-transpeptidase(GGT, IU/L) 18.29±9.42 20.07±10.07 <0.001 <8, >46 unit
Aspartate aminotransferase(AST, IU/L) 26.26±5.32 26.26±5.50 0.977 <5, >40 unit
Alanin transaminase(ALT, IU/L) 23.76±9.12 24.74±10.04 <0.001 <7, >56 unit
High density lipoproteincholesterol (HDLC, mg/dl) 49.83±8.76 49.52±8.36 0.203 <40 mg/dl, and history of hyperlipidemia
Low density lipoproteincholesterol (LDLC, mg/dl) 104.28±27.42 113.15±25.03 <0.001 >160 mg/dl, and history of hyperlipidemia
Total cholesterol (Tchol, mg/dl) 178.60±29.15 187.18±27.78 <0.001 >240 mg/dl, and history of hyperlipidemia
Triglyceride (TG, mg/dl) 119.95±36.16 119.73±37.09 0.820 >200 mg/dl, and history of hyperlipidemia